Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
What dose constraints, if any, do you use for the thyroid gland when treating with regional nodal irradiation for breast cancer?
Answer from: Radiation Oncologist at Community Practice
I have not used any constraints for thyroid for RNI but based on the volume, dose is confined to ipsilateral lobe of thyroid.
Sign In
or
Register
to read more
5899
Related Questions
Is it appropriate to use bolus with hypofractionated PMRT?
Is it appropriate to consider ultra-hypofractionation for phyllodes tumors of the breast when adjuvant radiotherapy is indicated?
What volumes and dose would you use for a chest wall recurrence in a patient who had previous mastectomy and completed only a partial prior course of PMRT?
How do you approach reirradiation in a patient who underwent breast-conserving surgery for recurrent breast cancer after initial lumpectomy and APBI?
Do you omit PMRT for patients who would have been eligible for NSABP B-51, but are found to have significant pure LVSI only, without stromal carcinoma, after neoadjuvant chemotherapy?
How do you manage a symptomatic primary breast tumor in a patient with metastatic disease?
Would you consider RNI alone without CW for an isolated nodal recurrence after treatment with mastectomy and SNB for an early-stage breast cancer with no prior RT?
Do you offer hypofractionation or RNI for a pT1N0 high-grade primary neuroendocrine carcinoma of the breast?
Would you offer PMRT to a patient with pTisN1a left breast DCIS?
In what patients is it inappropriate to offer DCISionRT testing?